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Abstract
Objectives: To assess and compare demographic and diagnostic characteristics of inpatients with mood disorders in Iran.
Materials and Methods: We collected the demographic, clinical, and treatment characteristics of patients, who were hospitalized
during five years from April 2006 to March 2010, in Iran hospital of psychiatry, a residency training center to evaluate the general
clinical picture of the disorder.
Results: Overall, 95.3% of subjects had a diagnosis of bipolar I disorder (BID), 2.5% were diagnosed as bipolar II disorder (BIID) and
1.3% and 0.9% met the criteria for major depressive disorder (MDD) and bipolar not otherwise specified (NOS), respectively. Com-
pared to patients with MDD and BIID, the onset of BID was at an earlier age (32.2± 1, 34.8± 1.5 and 29.9± 1.9 years old, respectively, P
< 0.001). In addition, a number of admissions, mean duration of each admission and number of treatments with electro-convulsive
therapy (ECT) were significantly higher in patients with BID.
Conclusions: Bipolar I disorder was the most common diagnosis for inpatients with mood disorders and a more severe course in
BID may indicate more severe impairments that would result in more severe disabilities.
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1. Background
Mood disorders including depressive and bipolar dis-
orders are one of the most frequent psychiatric disorders
in clinical settings as well as in the community (1).
According to previous studies, the lifetime prevalence
of major depressive disorder (MDD) was between 4.9 and
20 percent and the lifetime prevalence of bipolar I and
II disorders have been reported to be between 1.3% and
3.9% (2-6). Considering sub-threshold diagnostic criteria,
including one or two symptoms over a short time-period,
an additional 5.1% of the population could be categorized
as having a bipolar spectrum disorder (7). Depressive
disorders and bipolar disorders are responsible for 40.5%
and 7.0% of disability-adjusted life years (DALYs) caused by
mental and substance use disorders, respectively (8).
All mood disorders could have a negative impact on
quality of life and functioning and are concomitant with
psychiatric and medical morbidity and mortality (9-12),
and these features could lead to burnout in families and
are a heavy burden on the society (11-13). However, accord-
ing to previous results presented in numerous reports,
bipolar mood disorders have major differences with MDD
in clinical features, demographic attributes, response to
treatment and long-term course, which are precious in di-
agnosis and management. These differences include clin-
ical features such as age of onset, age of first treatment,
number of episodes, and demographic differences such as
gender ratio of the patients and their socio-economic sta-
tus; for example male to female ratio in bipolar I disorder
(BID) is about 1:1, and BID is concomitant with higher rates
of positive family history, larger number of episodes with
psychotic features, and higher probability of committed
suicide (14-19).
In general it is valuable to investigate the mentioned
features in patients with different subtypes of mood disor-
ders in different communities. Based on some studies, it
is supposed that somehow the course of mood disorders
is different in Iranian patients; for instance, in contrary
to other studies, in most of the Iranian bipolar patients
the disorder begins with a manic episode (20). It was also
found that there was no association between bipolar dis-
order and age or educational status in Iranian patients in
Copyright © 2016, Mazandaran University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons
Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in
noncommercial usages, provided the original work is properly cited.
Ghanbari Jolfaei A et al.
contrast to many Western studies, which showed associa-
tions of bipolar disorder with lower age and educational
level (4, 9, 21-24).
This confirms the need for further investigations in or-
der to gather more information about attributes of Iranian
patients with different subgroups of mood disorders (25).
Such investigations would enable us to have more precise
information about patients with mood disorder in Iran
that could be used in clinical decisions and health system
planning.
2. Objectives
The current study was designed to assess demographic
and diagnostic features of 3147 inpatients with mood disor-
ders in a psychiatric hospital in Tehran, Iran.
3. Materials and Methods
In a cross-sectional study, we collected, via a census
sampling method, the information of all inpatients hospi-
talized during five years from April 2006 to March 2010 in
Iran hospital of psychiatry, a university affiliated referral
mental hospital in Tehran through studying their medical
charts. This study was authorized by the research deputy
and ethics committee of the faculty of medicine, Iran Uni-
versity of medical sciences, Tehran, Iran and it conforms
to the provisions of the declaration of Helsinki on human
researches. All data were considered confidentially anony-
mous. Patients had already signed an informed consent
about application of their clinical data on records upon ad-
mission in the hospital, and the records of those who had
denied signing the consent were not used in this study.
The patients who were diagnosed with mood disorders
in the first hospitalization based on the diagnostic and sta-
tistical manual of mental disorders- 4th Ed-text revision
(DSM IV-TR) (21) by a clinical interview at admission by ex-
pert psychiatrists (who were faculty members of the Iran
University of Medical Sciences) were enrolled in the study.
In the mentioned hospital, the diagnoses were based on
DSM-IV-TR (diagnostic and statistical manual of mental dis-
orders criteria) using a nonstructural or semi-structured
interview. If the mood disorders were diagnosed to be sec-
ondary to substance abuse and dependency or any other
conditions (i.e. general medical conditions or induced
by medications) according to DSM-IV-TR, subjects were ex-
cluded from the study.
We gathered the demographic, clinical, and treatment
attributes of 3147 patients, including age, gender, date and
place of birth, home address, marital status, number of
children, occupational status, educational status, insur-
ance status, age of first episode, age of first hospitalization,
type of first episode, number of hospitalizations, dura-
tion of each hospitalization, psychiatric diagnosis during
each hospitalization, type of treatments (pharmacother-
apy, ECT) during each hospitalization, and history of alco-
hol and substance use.
3.1. Statistical Analysis
Data analysis were performed with SPSS 21.0 (IBM Inc.)
and differences between diagnostic categories were tested
with analysis of variance (ANOVA) test and if there were
global differences between categories, we used Tukey’s
HSD post hoc test to compare each pair of categories, and
we also used Chi square test to compare categorical vari-
ables in diagnostic groups of subjects. Statistical signifi-
cance level was set at P < 0.05.
4. Results
This study included 3147 patients initially admitted to
a university affiliated psychiatry hospital with diagnosis of
mood disorders; 66% of subjects were male and 34% were
female. In the first admission, most of the subjects ful-
filled the DSM-IV criteria for bipolar I disorder (BID) (87.8%),
3.5% met the criteria for major depressive disorder (MDD),
2.6% were diagnosed as bipolar II disorder (BIID) and 6.2%
fulfilled DSM-IV criteria for bipolar disorder-not otherwise
specified (NOS).
However, on later admissions, because of change of the
clinical picture, some of the diagnoses were changed and
finally 95.3% of subjects received the diagnosis of BID, 2.5%
were diagnosed as BIID and 1.3% and 0.9% met the criteria
for MDD and bipolar disorder-NOS, respectively. Diagnosis
changes are shown in Table 1. Diagnosis stability for all the
subjects was 92.1%; for subjects with first diagnosis of BID,
BIID, MDD and NOS diagnosis stability was 100%, 81.5%, 37.3%
and 14.4%, respectively (Table 1).
Age of onset of inpatients with BID (27.9±0.19 years
old) was earlier than patients with BIID and MDD (34.8 ±
1.5 and 32.2 ± 0.96 years old, respectively; P < 0.001). In
addition, age of their first hospitalization was significantly
younger in BIID compared to BID (P < 0.001, Table 2). More
males (65.4 - 66.1%) than females (33.9 - 34.6%) with BID and
BIID were admitted to the hospital compared to MDD, in
which more females (68.3%) with MDD had been admitted
to the hospital. Less than half of inpatients with BID/BIID
were married compared to all of the MDD inpatients (Ta-
ble 2). Educational level and health insurance coverage
was lower in patients with BID compared to other groups
while patients with MDD showed the highest unemploy-
ment rate among mood disorder groups in the study (Table
2).
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Table 1. Change in Diagnosis Between First Admission and Final Diagnosisa
Diagnosis at 1st Hospitalization Final Diagnosis Total
BID MDD BIID Other
BID 2762 (100%) 0 (0%) 0 (0%) 0 (0%) 2762
MDD 69 (62.7%) 41 (37.3%) 0 (0%) 0 (0%) 110
BIID 15 (18.5%) 0 (0%) 66 (81.5%) 0 (0%) 82
Other 154 (79.4%) 0 (0%) 12 (6.2%) 28 (14.4%) 194
Total 3000 41 78 28
aChi Square P value <0.01.
Indices related to admissions such as number of ad-
missions, mean duration of each admission, and number
of electro-convulsive therapy (ECT) treatments were signif-
icantly higher in patients with BID than BIID, MDD and
other mood disorders (P < 0.001, Table 2).
About two-third (65.1%) of the subjects finally di-
agnosed with BID, had their index episode as ma-
nia/hypomania episode and depressive and mixed
episodes were seen during the first episode of the dis-
order in 30.3% and 2.7% of patients with BID (Table 2).
5. Discussion
Patients with BID were the most prevalent group
among hospitalized psychiatry patients in our study dur-
ing a period of five years that along with possible referral
bias to the hospital of study may indicate a greater need for
inpatient care for the disorder.
The course and characteristics of mood disorders
showed differences in our study. Recently, many studies
have compared mood disorder subtypes, such as BID, BIID,
MDD and bipolar disorder-NOS. Studies reported a num-
ber of differences in clinical and demographic characteris-
tics of patients with bipolar or major depressive disorders,
which are consistent with the results of our study. Bipolar
I disorder can be distinguished from MDD and BIID by hav-
ing an earlier age at onset, an earlier first lifetime hospital-
ization, more episodes, higher number of hospitalizations,
higher rates of psychiatric comorbidities, higher rates of
divorce, separation or being single and higher likelihood
of unemployment and poor socio-economic status (26, 27),
while some authors reported less severe symptoms along
with more chronic course and frequent episodes in BIID
than in BID, (28, 29) as well as more comorbidities (30, 31)
and more unstable interpersonal relationships and social
adjustment (32) in BIID compared to BID. Considering all
these findings it could be reasonable to propose charac-
teristics such as higher number of hospitalizations, longer
duration in each admission, and higher number of ECT
treatments in patients with BID as the indicator of severity
of BID course, in comparison to other mood disorders.
In this study the educational level of bipolar-one pa-
tients was also lower than patients with other mood disor-
ders and considering early age of onset of the disorder in
mind, this could be related to the disruptive nature of the
disorder in mental functioning needed to develop routine
educational needs. Considering the wide range of data on
cognitive impairments in patients with mood disorders in-
cluding bipolar disorders, this also may highlight the need
for more attention in screening and management of early
onset mood disorders and consideration of children with
these disorders as those with special needs in education
to help them acquire developmental and educational re-
quirements to achieve better function as part of the society
in the future (33-35).
The reason that the majority of our patients were male
may have been due to the fact that the number of beds in
Iranian hospitals is twice for males than those for females.
However, in accordance with other studies, the number of
female patients with MDD is still twice that of male MDD
patients. Therefore, considering the different gender ra-
tio in BID/BIID and MDD, we can assume that aside from
selection bias due to inequality of gender ratio in beds,
there maybe more males with BID/BIID as more women
with MDD need inpatient care (3, 7, 25, 36).
Altogether, considering the severe course in BID and
lower education levels achieved by patients with BID com-
pared to BIID/MDD it seems that the chance and poten-
tials for social development indicated by having relation-
ships, marital status and employment is poor in patients
with mood disorders, especially BID. In comparison with
other studies, Iranian patients tend to have lower rate of
divorce and education and higher rate of unemployment,
health insurance and bachelor’s degree (25, 37-39). The
lower rate of divorce and employment in the general pop-
ulation of Iran compared to reference countries of afore-
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Table 2. Comparison of Demographic Characteristics and Clinical Features of Mood Disorders
BID BIID MDD Other P Value
No. (%) 3000 (95.3) 78 (2.5) 41 (1.3) 28 (0.9)
Age at onset, y, mean± SE 27.9± 0.19 34.8± 1.5 32.2± 0.96 29.5± 0.1 < 0.001a
Age at first admission; y, mean± SE 32.5± 0.2 36.1± 1.2 32.2± 0.96 37.0± 1.2 0.006b
Gender, No. (%) < 0.001
Male 1984 (66.1) 51 (65.4) 13 (31.7) 28 (100)
Female 1016 (33.9) 27 (34.6) 27 (68.3) 0 (0)
Marital Status, No. (%) < 0.001
Married 1414 (47.1) 39 (50) 41 (100) 14 (50)
Single 1258 (41.9) 39 (50) 0 (0) 14 (50)
Divorced 328 (10.9) 0 (0) 0 (0) 0 (0)
Education level, No. (%) < 0.001
Illiterate 173 (5.8) 0 (0) 0 (0) 0 (0)
Under diploma 1747 (58.2) 25 (32) 27 (65.9) 0 (0)
Diploma 828 (27.6) 40 (51.3) 14 (34.1) 28 (100)
College 252 (8.4) 13 (16.7) 0 (0) 0 (0)
Health insurance, No. (%) 2778 (92.6) 78 (100) 41 (100) 14 (50) < 0.001
Occupation status, No. (%) < 0.001
Clerk 139 (4.6) 14 (17.9) 0 (0) 14 (50)
Worker 346 (11.5) 12 (15.4) 0 (0) 0 (0)
Self employed 361 (12) 0 (0) 0 (0) 0 (0)
Retired 67 (2.2) 13 (16.7) 0 (0) 0 (0)
Unemployed 1433 (47.6) 13 (16.7) 28 (68.3) 0 (0)
Housewife 654 (21.8) 13 (16.7) 28 (68.3) 0 (0)
Admission No, mean± SE 2.39± 0.04 1.97± 0.13 1.3± 0.07 1± 0 < 0.001c
Mean duration at admission, d, Mean± SE 32.1± 0.21 22.8± 1.2 28.7± 2.0 18.5± 2.8 < 0.001c
Number of admission with ECT, mean± SE 0.39± 0.01 0.17± 0.04 0± 0 0± 0 < 0.001c
Index episode, No. (%) < 0.001
Mania/hypomania 1953 (65.1) 17 (21.8) 0 (0) 28 (100)
Depressive 910 (30.3) 61 (78.2) 41 (100) 0 (0)
Mixed 81 (2.7) 0 (0) 0 (0) 0 (0)
Other, NI 56 (1.9) 0 (0) 0 (0) 0 (0)
Abbreviations: SE: Standard Error, NI: Not Identified.
aPost Hoc test showed the differences only between with BID group with BIID and MDD not with others.
bPost Hoc test showed the differences only between with BID group with BIID not with MDD and others.
cPost Hoc test showed the differences only between with BID group with other groups while the other groups showed no significant differences in subgroup analyses.
mentioned studies may be somewhat consistent with cul-
tural differences (40-42). Furthermore, Iran hospital is lo-
cated in a low socioeconomic region, outside of Tehran and
the economic and educational properties of the patients
of this study couldn’t be generalized to all the psychiatric
inpatients of the country. Having higher rate of insurance
could be related to social welfare programs in Iran during
the recent years.
In our study, age at onset and age of the first admis-
sion for BID was also higher than other studies (25, 37, 38).
One must note that in our study the difference between age
at onset and age at first admission for patients with BID,
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BIID and other mood disorders were 4.6, 1.3 and 7.5 years,
respectively, and MDD patients are assumed to be admit-
ted at the age of onset. So for most of the patients the age
at onset in our study was close to age of first admission.
We in our study estimated the age at onset based on the
history report at first or subsequent admission and this of
course is not an accurate estimation. Age of onset for BID in
large scale studies in clinical and general population were
earlier than our study patients (43, 44). Overlooking the
symptoms of mania, lack of insight into manic symptoms
and recall bias could be the reason for greater age at on-
set of the disorder in our study. In addition, misdiagnoses
and the stigma of having mental disorders as a barrier to
punctual hospitalization may be the causes of greater age
of first admission.
Consistent with the data of previous Iranian studies
on bipolar patients and in contrast to studies from other
countries, the disorder begins in most of the patients with
a manic phase and it is highly recommended to design nu-
merous studies with the aim of investigation of probable
etiologies such as genetics (20, 45, 46). Some questions
about greater acceptability and tolerability of depressive
symptoms and episodes, rather than behaviorally disrup-
tive manic episodes, and mental health system profession-
als’ attitude toward outpatient/inpatient management of
depressive/manic episodes should be the subject of further
investigations.
Rate of health insurance shows better medical insur-
ance coverage in Iran compared to other countries (25, 37,
38).
Recurrent hospitalization of 62.7%, 18.5% and 79.4% of
patients with the diagnosis of MDD, bipolar NOS and BIID,
respectively, fulfilled the criteria of BID, which seems un-
expectedly high. Over a prospective observation, carried
out by Akiskal et al. (32) on 559 patients with MDD during
a period of up to 11 years, the diagnosis of eight patients
was changed to BIID (8.6%) and the diagnosis of 22 patients
changed to bipolar I (BPI) (3.9%) (47). In that study, sever-
ity and psychotic features were the predictors of change
in diagnosis. If hospitalization could be considered as the
severity, the high rate of changing the diagnosis in this
study could be justified. Long-term follow-up studies of pa-
tients with mood disorders could result in more reliable
data on diagnosis constancy during the course of illness
and the ongoing study of bipolar disorder patients follow-
up (BDPF) in Iran by Shabani et al. could answer this issue
more reliably in the near future (48).
In conclusion our findings revealed that there are
some substantial demographic differences in patients
with mood disorders in Iran and studies from other coun-
tries are needed to further investigate factors leading to
this finding. In addition, high rate of diagnosis switch be-
tween MDD and other mood disorders in first admissions
to BID in further admissions along with stability of BIID di-
agnosis should be alarming for clinicians to be more alert
about the possibility of differential bipolar diagnoses.
Our study was conducted based on data from medical
records of 3147 patients from a referral psychiatry hospi-
tal that lacked appropriate assurance of quality and consis-
tency, however considering that the hospital was a univer-
sity affiliated residency training center where routine stan-
dards of diagnosis based on DSM-IV-TR criteria for mental
disorders were used, the authors assumed acceptable re-
quirements for using the findings.
As other record-based cross-sectional studies there
were limitations in quality control and testing homogene-
ity of data in this study that can affect the results, while
long-term follow up of the patients could partially over-
come these limitations by obtaining more information on
diagnosis and characteristics of the subjects in recurrent
admissions. We were unable to follow the outcome of pa-
tients, who were lost to follow up and who were not re-
admitted to our hospital after their last admissions thus re-
admission and recurrence rate should be considered as the
lowest estimate. Further ongoing investigations especially
cohort of the subject with mood disorders could result in
better and more accountable findings.
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